- Novus Therapeutics (NASDAQ:NVUS) has slipped 7.8% in Friday postmarket action after a shareholder filing to offer just over 7.07M shares.
- The company won't receive any proceeds from any sale of shares.
- The company has just 12.9M shares outstanding. Along with several individuals, selling stockholders in the filing include entities affiliated with OrbiMed Israel Partners (holders of a 31.37% stake); BVF Partners (a 9.16% stake); Armistice Capital Master Fund (a 4.99% stake); and Lincoln Park Capital Fund (also a 4.99% stake).
Novus Therapeutics -7.8% on stockholder offer of 7.07M shares
Recommended For You
More Trending News
About ELDN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ELDN | - | - |
Eledon Pharmaceuticals, Inc. |